The Life Sciences sector includes companies involved in biopharmaceuticals, medical manufacturing and distribution, and bio products.
Weekend Unlimited Inc. is capitalizing on vast industry relationships to establish a portfolio of cannabis brands throughout North America and internationally. Weekend Unlimited’s brand portfolio includes geographic footholds in California, Washington State, British Columbia and Las Vegas, establishing a strong, versatile foundation for substantial growth. The product portfolio will be focused under the headings of flower, edibles and extracts.
Wikileaf.com is the leading price comparison site to help cannabis consumers find location-based pricing information about individual marijuana strains and products – at the critical moment when they are deciding where to spend their money.
Each day, tens of thousands of cannabis consumers use the Wikileaf website to find and interact with local dispensaries and brands to learn about and find the best prices for their desired cannabis strains and products.
Dispensaries and cannabis brands in turn use our free digital listing services to engage with consumers as an additional point of consumer engagement. Our active database of over 4,300 licensed cannabis dispensaries and brands attracts a vibrant community of cannabis users seeking information on pricing and cannabis strains.
Wildflower is a holistic wellness company headquartered in Vancouver building reputable brands and quality products that incorporate the synergistic effects of plants and their extracts.
Willow Biosciences are pioneers in the biotechnology sector and have developed the only fully-integrated synthetic biology solution for opioid biosynthesis. We are now leveraging our unique design-build process to the biosynthesis of cannabinoids.
World-Class develops industrial grade extraction and processing systems for cannabis and hemp and is establishing extraction and processing facilities through strategic joint ventures. World-Class is commercializing its processes by providing cost-effective and at-scale production to produce high margin, high-quality extracts, premium derivative products, and consumer brands. World-Class operates through two wholly-owned subsidiaries: Soma Labs Scientific Ltd. and Greenmantle Products Ltd.
XORTX Therapeutics Inc. is a BioPharmaceutical company focused on developing innovative therapies to treat progressive kidney disease. XORTX has lead programs to develop treatments for progressive kidney disease due to diabetes, diabetic nephropathy and polycystic kidney disease. Secondary programs focus on developing therapies for health consequences that accompany pre-diabetes, diabetes and cardiovascular disease. Additional information on XORTX Therapeutics is available at www.XORTX.com.
XPhyto is a science-based cannabis company focused on formulation, clinical validation, and emerging European markets. XPhyto’s 100% owned German subsidiary, Bunker Pflanzenextrakte GmbH, has been granted a unique German cannabis cultivation and extraction licence for scientific purposes by the German Federal Institute for Drugs and Medical Devices (BfArM). XPhyto is pursuing additional opportunities in Germany including cultivation, processing, manufacturing, import, and distribution. In Canada, two exclusive 5-year engagements with the Faculty of Pharmacy at a major Canadian university provide certified extraction, isolation, and formulation facilities, drug research and development expertise, as well as commercial analytical testing capability.
Xtraction Services Holding Inc. ('XS") specializes in providing equipment leasing solutions in the United States to owner/operators of cannabis and hemp companies, including cultivators, oil processors, manufacturers, testing laboratories, among others, allowing them to affordably spread their payments over time. In addition, XS provides a range of leasing products and consulting services, including equipment selection and procurement, through its network of preferred vendor partnerships with original equipment manufacturers and equipment distributors. XS's management team is successful in scaling high growth businesses, product development, finance, and operational best practices providing a proven business model.
Investor Note: In addition to the 29,832,122 Subordinate Voting Shares that are listed and trading, there are 18,096,126 Proportionate Voting Shares reserved for issuance pursuant to the conversion rights attached to the other classes of equity shares that are issued and outstanding but not listed, and that are currently locked up for a three-year period. The total number of issued shares assuming all are converted into the listed class would be 47,928,248.